Cryo-Cell International (CCEL) vs Mangoceuticals (MGRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cryo-Cell International is the larger company by market cap ($31.5 million vs $9.4 million), about 3.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CCEL | MGRX |
|---|---|---|
| Share price | $3.91 | $0.4374 |
| Market cap | $31.52M | $9.43M |
| 1-day change | 0.00% | -1.42% |
| YTD return | +13.66% | — |
| 1-year return | -11.34% | — |
| 5-year return | -70.27% | — |
| Forward P/E | 195.50 | — |
| EPS (TTM) | $-0.31 | $-1.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.90 | $2.75 |
| 52-week low | $2.72 | $0.162 |
| Distance from 52-week high | -20.20% | -84.09% |
| Average volume | 23.32K | 12.83M |
| Shares outstanding | 8.06M | 21.57M |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cryo-Cell International is about 3.3 times larger than Mangoceuticals by market value ($31.52M vs $9.43M).
CCEL vs MGRX FAQ
Which is bigger, Cryo-Cell International or Mangoceuticals?
Cryo-Cell International (CCEL) is larger, with a market capitalization of $31.52M compared with $9.43M for Mangoceuticals (MGRX).
Are Cryo-Cell International and Mangoceuticals in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.